Effectiveness of a Standardized Bereavement Intervention in Primary Care

July 9, 2014 updated by: Carlos III Health Institute

Effectiveness of "Primary Bereavement Care" (PBC) in Widows: A Cluster Randomized Controlled Trial

The purpose of this study is to evaluate the efficacy of "Primary Bereavement Care" (PBC) -a standardized bereavement intervention- delivered by family physicians (FP), in widows.

Study Overview

Detailed Description

Nowadays there is little evidence about what is the best bereavement intervention in primary care and each family physician (FP) assists bereaved people in a different way. The death of a loved one is the most stressful life event that can face a person; in fact, bereavement is associated with an increased risk of depression, generalized anxiety and panic disorder, alcohol abuse and use of medications, sudden cardiac events, suicide, and an increased demand for health resources. The FP is the only specialist who -through his position in the health system and in the community- can give emotional support to the bereaved and simultaneously deal with the health problems associated with the process. In response to this, our work group has designed a guide specifically for FP: Primary Bereavement Care (PBC), and is currently testing its efficacy in a randomized controlled study.

Comparison (s): Recently widows attended by FP trained in PBC through seven PBC sessions, compared to recently widows attended by FP not trained in PBC through seven "ordinary" sessions.

Study Type

Interventional

Enrollment (Actual)

87

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Bizkaia
      • Bilbao, Bizkaia, Spain, 48014
        • Primary Care Research Unit of Bizkaia, Basque Health Service/Osakidetza

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 70 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Partner death during the last 3 months.

Exclusion Criteria:

  • Partner death through suicide or AIDS.
  • Son or daughter death during the last 3 years.
  • Parent or sibling death the year before.
  • Alcohol or drug abuse.
  • Psychotic disorder or dementia.
  • To be confined to bed
  • Illiteracy.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 1
a standardized bereavement intervention in Primary Care
Other Names:
  • Bereavement Primary Care
  • Bereavement Intervention in Primary Care
  • Grief Intervention in Primary Care
Active Comparator: 2
the non-standardized bereavement care that usually provided family physicians in primary care
Other Names:
  • The current grief care in primary care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Texas Revised Inventory of Grief (TRIG)
Time Frame: at 3, 9, 15 and 21 months since death
at 3, 9, 15 and 21 months since death

Secondary Outcome Measures

Outcome Measure
Time Frame
Grief Experience Inventory (GEI)
Time Frame: at 3, 9, 15 and 21 months since death
at 3, 9, 15 and 21 months since death
General Health Questionnaire - 28 items (GHQ-28)
Time Frame: at 3, 9, 15 and 21 months since death
at 3, 9, 15 and 21 months since death
SF-36 Health Profile (SF-36)
Time Frame: at 3, 9, 15 and 21 months since death
at 3, 9, 15 and 21 months since death

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jesus A. Garcia, MD, Primary Care Research Unit of Bizkaia, Basque Health Service/Osakidetza.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2001

Primary Completion (Actual)

April 1, 2005

Study Completion (Actual)

December 1, 2006

Study Registration Dates

First Submitted

August 22, 2005

First Submitted That Met QC Criteria

August 22, 2005

First Posted (Estimate)

August 23, 2005

Study Record Updates

Last Update Posted (Estimate)

July 10, 2014

Last Update Submitted That Met QC Criteria

July 9, 2014

Last Verified

March 1, 2008

More Information

Terms related to this study

Other Study ID Numbers

  • PI020827
  • 200011007

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Grief

Clinical Trials on Primary Bereavement Care

3
Subscribe